Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure).
about
Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical ImplicationsThe role of titin and extracellular matrix remodelling in heart failure with preserved ejection fractionBiomarkers in heart failure with preserved ejection fractionClinical Phenotypes in Heart Failure With Preserved Ejection FractionPlasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction StudyClinical Correlates and Prognostic Value of Plasma Galectin-3 Levels in Degenerative Aortic Stenosis: A Single-Center Prospective Study of Patients Referred for Invasive TreatmentAging and the cardiac collagen matrix: Novel mediators of fibrotic remodellingRole of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use.Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation.Clinical Phenotyping of Heart Failure with Biomarkers: Current and Future Perspectives.Heart failure and kidney dysfunction: epidemiology, mechanisms and management.The potential of targeting epigenetic regulators for the treatment of fibrotic cardiac diseases.Heart failure with preserved ejection fraction: a nephrologist-directed primer.Interleukin-1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D-HART2).Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).Galectin-3 levels relate in children to total body fat, abdominal fat, body fat distribution, and cardiac size.Galectin-3 Reflects the Echocardiographic Grades of Left Ventricular Diastolic Dysfunction.Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure.Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview.High-sensitivity C-reactive protein in heart failure with preserved ejection fraction
P2860
Q26749488-EDC0DB5E-8F37-4232-98E5-47324464B112Q26765101-EEA6E1F7-09D3-40D7-9DBC-12CB07F3ED8CQ26768192-6CC41602-E7AA-416E-81D6-A8DC8A113BE5Q28073079-38F0B615-6C55-4D56-9E29-707E975747D3Q31036336-EF9F1FB4-8315-4174-97BA-A521A829673BQ33754895-CA9944DD-8D90-422B-BFF2-085CF05C05CFQ37096257-AB676A57-09AA-4D5C-9DA4-4793000B0C80Q38614176-817DFC7C-1C6E-46D3-B5C1-39BD6D76EB40Q38727741-00B81228-592C-4481-B5C1-C8DAC9A40DDBQ38756838-D6FE8A6E-A840-4B73-8BBA-F17F6D03AF2EQ38826590-787767F0-F5D1-4F67-AD0C-56FF7C2F7BD8Q38828267-C34D14E1-7FD1-43F0-B6BC-3C4F3DAC00BBQ39301622-27AB1A11-8591-4F0C-8332-262615178F99Q45058507-1CC49305-83BE-4236-ADCC-C328739EEE7EQ47329197-7D5B407A-A95B-4C2B-BE50-835D1213CD24Q48043409-500AA00F-9D93-421F-B7CA-44CF221582B4Q52610863-8F0B2289-21D9-4F8A-9FEA-42A501BDD192Q55230733-1EBD046D-3D6D-49D8-A971-56F6E4AA4BC0Q55610979-890FF6C3-EA99-49CB-BBB4-DFB884548228Q58775176-5F34C8E5-AC7F-40A6-B2A2-F7107558CF1D
P2860
Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure).
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Galectin-3 in heart failure wi ...... y in Diastolic Heart Failure).
@ast
Galectin-3 in heart failure wi ...... y in Diastolic Heart Failure).
@en
type
label
Galectin-3 in heart failure wi ...... y in Diastolic Heart Failure).
@ast
Galectin-3 in heart failure wi ...... y in Diastolic Heart Failure).
@en
prefLabel
Galectin-3 in heart failure wi ...... y in Diastolic Heart Failure).
@ast
Galectin-3 in heart failure wi ...... y in Diastolic Heart Failure).
@en
P2093
P2860
P1433
P1476
Galectin-3 in heart failure wi ...... ty in Diastolic Heart Failure)
@en
P2093
Eugene Braunwald
Horng H Chen
Jose Nativi-Nicolau
Margaret M Redfield
Omar F AbouEzzeddine
Phillip Haines
Russell P Tracy
Susanna Stevens
P2860
P304
P356
10.1016/J.JCHF.2014.10.009
P577
2015-03-01T00:00:00Z